BRD4 and cancer: In 2022, Wu et al. demonstrated that suppression of lncRNA MALAT1 (Metastasis-Associated Lung Adenocarcinoma Transcript 1) inhibited the cancer stem cell (CSC)-like properties of laryngocarcinoma cells via miR-708-5p/YAP1/BRD4 axis (Wu et al., 2022).